EVA – Complete Vaginal Tightening and Rejuvenation Platform
EVATM by Novaclinical offers a safe, effective and comfortable non-ablative solution for the treatment of the most common gynecological conditions, including vulvo-vaginal atrophy (VVA), symptoms of Genitourinary Syndrome of Menopause (GSM), vaginal laxity, pain or reduced sensitivity during sexual intercourse, mild stress urinary incontinence and vulvar rejuvenation.
EVATM, unlike any other device on the market, employs innovative Dynamic Quadri-polar radiofrequency (DQRFTM) and Ultra Pulsed Radioporation (UPRTM) technologies. DQRFTM energy acts by heating the connective tissue of the vaginal wall to 40°C to 42°C to induce collagen contraction, neocollagenesis, vascularisation, and growth factor infiltration that ultimately revitalises and restores the elasticity and moisture of the vaginal mucosa.
UPRTM acts by opening aqueous channels in cell membranes through modulation of the effects of the DQRFTM technology. This increases the membrane permeability and thus facilitates the penetration of active ingredients such as hyaluronic acid. This enhances the vulvovaginal treatment and allows for more immediate results.
DQRFTM technology utilises four electrode configuration probes (360° configuration) designed to focus energy emission precisely on three different tissue layers, reaching the required depth to stimulate subdermal collagen production and tissue remodelling, whilst leaving the surrounding tissue unharmed.
Designed and manufactured entirely in Italy, EVATM is one of Novaclinical’s leading products, backed by scientific studies clinically proving its efficacy and perceived improvement to life quality.